Skip to main content
Erschienen in: World Journal of Surgical Oncology 1/2014

Open Access 01.12.2014 | Case report

Surgical treatment of a solitary pulmonary metastasis from eyelid sebaceous carcinoma: report of a case

verfasst von: Kaoru Kaseda, Takashi Ohtsuka, Yuichiro Hayashi, Katsura Emoto, Keisuke Asakura, Ikuo Kamiyama, Taichiro Goto, Mitsutomo Kohno

Erschienen in: World Journal of Surgical Oncology | Ausgabe 1/2014

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Background

Ocular sebaceous carcinoma is an uncommon, aggressive ocular neoplasm with potential for regional and distant metastasis.

Case presentation

A 77-year-old woman was found to have a solitary pulmonary lesion 6 years after the initial treatment of sebaceous carcinoma of the eyelid. Video-assisted lung wedge resection of an undetermined pulmonary nodule was carried out successfully. Microscopically, the tumor showed foamy cytoplasm and atypical nuclei, consistent with metastasis of eyelid sebaceous carcinoma.

Conclusion

This is the first case report of resected solitary pulmonary metastasis of eyelid sebaceous carcinoma. Pulmonary resection is a good option for the treatment and diagnosis of metastatic eyelid sebaceous carcinoma.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1477-7819-12-108) contains supplementary material, which is available to authorized users.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

KK and TO wrote the manuscript. KK, TO, KA, and IK performed surgery. YH and KE carried out the pathological examination. MK and TG were involved in the final editing. All authors approved the final manuscript.
Abkürzungen
CT
Computed tomography
FDG
Fluorodeoxyglucose
PET
Positron emission tomography.

Background

Sebaceous carcinoma of the eyelid is a relatively rare malignant tumor, and accounts for less than 1% of all eyelid tumors [1]. As well as being a rare tumor, sebaceous carcinoma can mimic other benign inflammatory and malignant processes, thus errors or delays in diagnosis are not unusual [25]. Although local management strategies for this tumor have previously been described [610], very few reports have focused on the patterns of metastasis of this tumor and the treatment strategies for such metastases [7, 8]. Here, we report a case of solitary lung metastasis of eyelid sebaceous carcinoma, and discuss the clinical implication of surgery for a solitary pulmonary metastasis from sebaceous carcinoma.

Case presentation

A 77-year-old woman underwent left upper lid resection in April 2006 for sebaceous carcinoma of the eyelid. The surgical margin was negative for cancer cells. In January 2008, she had developed a recurrence in the left upper eyelid, and underwent radiotherapy with a total dose of 57.6 Gy of proton beam therapy followed by orbital exenteration of the left eye [11, 12]. In July 2012, positron emission tomography–computed tomography (PET-CT) revealed a solitary pulmonary nodule 0.5 cm in size in the right upper lobe of the patient’s lung, which had increased to 1.1 cm by September 2013 (Figure 1A). PET-CT revealed a focus of increased uptake in that nodule, with a standardized uptake value of 3.7 (Figure 1B). There was no evidence of other metastatic disease on PET-CT scans. In September 2013, the patient underwent video-assisted thoracoscopic wedge resection of the pulmonary nodule. Frozen sections using oil red O stain revealed accentuation of lipid and presences of foamy cytoplasm in tumor cells, which was positive for lipid staining (Figure 2). Permanent histology demonstrated tumor cells with foamy cytoplasm and atypical nuclei, accompanying numerous lipid globules within the cytoplasm (Figure 3), consistent with metastasis of eyelid sebaceous carcinoma. At the last follow-up, 7 months after resection, there was no loco-regional recurrence or distant metastasis of the tumor after surgery.

Discussion

Sebaceous carcinoma of the eyelid refers to a group of carcinomas derived from sebaceous gland cells that occur in the ocular adnexa. It can be invasive in the eyelid and conjunctiva, and can metastasize to regional lymph nodes and distant organs [8, 13, 14]. Treatment strategies for primary eyelid sebaceous carcinoma are surgery, radiotherapy, and chemotherapy [1517]. Distant hematogenous metastases to the lung, liver, and brain have a mortality rate as high as 30% [16, 18]. However, few reports demonstrated the surgical treatment of metastatic eyelid sebaceous carcinoma.
Standard treatment strategy for pulmonary metastatic sebaceous carcinoma has not yet been established because of the limited number of cases. Chemotherapy regimens in existing reports are largely based on the combination regimens commonly used in the treatment of other forms of poorly differentiated carcinomas of the head and neck region [19, 20]. Husain et al. reported combined chemotherapy of carboplatin and docetaxel for the patient who had multiple lung and lymph node metastases, which resulted in a 30% decrease in tumor size, but the efficacy of this regimen for sebaceous carcinoma has not yet been fully evaluated [21]. Radiotherapy for primary eyelid sebaceous carcinoma was described in several reports; however, there have been no reports describing radiotherapy for pulmonary metastatic eyelid sebaceous carcinoma [22, 23]. Resection of pulmonary metastases in patients with sebaceous carcinoma is controversial. However, our case suggests that a surgical approach to lung metastasis of eyelid sebaceous carcinoma could prolong survival in certain subgroups of patients, namely, those with a limited number of metastatic nodules or a significant disease-free interval.
The possibility of metastasis from eyelid sebaceous carcinoma or primary lung cancer cannot be predicted only on the basis of radiologic findings or disease-free interval. In the present case, we could successfully differentiate solitary lung metastasis of eyelid sebaceous carcinoma from primary lung cancer using oil red O stain, which stains lipid has a red color, on frozen sections.

Conclusion

We report a rare case of solitary lung metastasis of eyelid sebaceous carcinoma, which was successfully resected and differentiated from primary lung cancer using oil red O stain on frozen sections. Pulmonary resection is a good option for the treatment and diagnosis of metastatic eyelid sebaceous carcinoma.
Written informed consent was obtained from the patient for the publication of this case presentation and accompanying images. A copy of the written consent is available for the review by the Editor-in-Chief of this journal.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
The Creative Commons Public Domain Dedication waiver (https://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

KK and TO wrote the manuscript. KK, TO, KA, and IK performed surgery. YH and KE carried out the pathological examination. MK and TG were involved in the final editing. All authors approved the final manuscript.
Anhänge

Authors’ original submitted files for images

Literatur
1.
Zurück zum Zitat Cook BE, Bartley GB, Cook BE, Bartley GB: Treatment options and future prospects for the management of eyelid malignancies: an evidence-based update. Ophthalmology. 2001, 108: 2088-2209. 10.1016/S0161-6420(01)00796-5. quiz 2099–2100, 2121CrossRefPubMed Cook BE, Bartley GB, Cook BE, Bartley GB: Treatment options and future prospects for the management of eyelid malignancies: an evidence-based update. Ophthalmology. 2001, 108: 2088-2209. 10.1016/S0161-6420(01)00796-5. quiz 2099–2100, 2121CrossRefPubMed
2.
Zurück zum Zitat Lai TF, Huilgol SC, Selva D, James CL: Eyelid sebaceous carcinoma masquerading as in situ squamous cell carcinoma. Dermatol Surg. 2004, 30: 222-225. 10.1111/j.1524-4725.2004.30069.x.PubMed Lai TF, Huilgol SC, Selva D, James CL: Eyelid sebaceous carcinoma masquerading as in situ squamous cell carcinoma. Dermatol Surg. 2004, 30: 222-225. 10.1111/j.1524-4725.2004.30069.x.PubMed
3.
Zurück zum Zitat Leibovitch I, Selva D, Huilgol S, Davis G, Dodd T, James CL: Intraepithelial sebaceous carcinoma of the eyelid misdiagnosed as Bowen’s disease. J Cutan Pathol. 2006, 33: 303-308. 10.1111/j.0303-6987.2006.00423.x.CrossRefPubMed Leibovitch I, Selva D, Huilgol S, Davis G, Dodd T, James CL: Intraepithelial sebaceous carcinoma of the eyelid misdiagnosed as Bowen’s disease. J Cutan Pathol. 2006, 33: 303-308. 10.1111/j.0303-6987.2006.00423.x.CrossRefPubMed
4.
Zurück zum Zitat Pereira PR, Odashiro AN, Rodrigues-Reyes AA, Correa ZM, de Souza Filho JP, Burnier MN: Histopathological review of sebaceous carcinoma of the eyelid. J Cutan Pathol. 2005, 32: 496-501. 10.1111/j.0303-6987.2005.00371.x.CrossRefPubMed Pereira PR, Odashiro AN, Rodrigues-Reyes AA, Correa ZM, de Souza Filho JP, Burnier MN: Histopathological review of sebaceous carcinoma of the eyelid. J Cutan Pathol. 2005, 32: 496-501. 10.1111/j.0303-6987.2005.00371.x.CrossRefPubMed
5.
Zurück zum Zitat Sinard JH: Immunohistochemical distinction of ocular sebaceous carcinoma from basal cell and squamous cell carcinoma. Arch Ophthalmol. 1999, 117: 776-783. 10.1001/archopht.117.6.776.CrossRefPubMed Sinard JH: Immunohistochemical distinction of ocular sebaceous carcinoma from basal cell and squamous cell carcinoma. Arch Ophthalmol. 1999, 117: 776-783. 10.1001/archopht.117.6.776.CrossRefPubMed
6.
Zurück zum Zitat Chao AN, Shields CL, Krema H, Shields JA: Outcome of patients with periocular sebaceous gland carcinoma with and without conjunctival intraepithelial invasion. Ophthalmology. 2001, 108: 1877-1883. 10.1016/S0161-6420(01)00719-9.CrossRefPubMed Chao AN, Shields CL, Krema H, Shields JA: Outcome of patients with periocular sebaceous gland carcinoma with and without conjunctival intraepithelial invasion. Ophthalmology. 2001, 108: 1877-1883. 10.1016/S0161-6420(01)00719-9.CrossRefPubMed
7.
Zurück zum Zitat Shields JA, Demirci H, Marr BP, Eagle RC, Shields CL: Sebaceous carcinoma of the eyelids: personal experience with 60 cases. Ophthalmology. 2004, 111: 2151-2157. 10.1016/j.ophtha.2004.07.031.CrossRefPubMed Shields JA, Demirci H, Marr BP, Eagle RC, Shields CL: Sebaceous carcinoma of the eyelids: personal experience with 60 cases. Ophthalmology. 2004, 111: 2151-2157. 10.1016/j.ophtha.2004.07.031.CrossRefPubMed
8.
Zurück zum Zitat Shields JA, Demirci H, Marr BP, Eagle RC, Shields CL: Sebaceous carcinoma of the ocular region: a review. Surv Ophthalmol. 2005, 50: 103-122. 10.1016/j.survophthal.2004.12.008.CrossRefPubMed Shields JA, Demirci H, Marr BP, Eagle RC, Shields CL: Sebaceous carcinoma of the ocular region: a review. Surv Ophthalmol. 2005, 50: 103-122. 10.1016/j.survophthal.2004.12.008.CrossRefPubMed
9.
Zurück zum Zitat Yen MT, Tse DT, Wu X, Wolfson AH: Radiation therapy for local control of eyelid sebaceous cell carcinoma: report of two cases and review of the literature. Ophthal Plast Reconstr Surg. 2000, 16: 211-215. 10.1097/00002341-200005000-00008.CrossRefPubMed Yen MT, Tse DT, Wu X, Wolfson AH: Radiation therapy for local control of eyelid sebaceous cell carcinoma: report of two cases and review of the literature. Ophthal Plast Reconstr Surg. 2000, 16: 211-215. 10.1097/00002341-200005000-00008.CrossRefPubMed
10.
Zurück zum Zitat Wang JK, Liao SL, Jou JR, Lai PC, Kao SC, Hou PK, Chen MS: Malignant eyelid tumours in Taiwan. Eye (Lond). 2003, 17: 216-220. 10.1038/sj.eye.6700231.CrossRef Wang JK, Liao SL, Jou JR, Lai PC, Kao SC, Hou PK, Chen MS: Malignant eyelid tumours in Taiwan. Eye (Lond). 2003, 17: 216-220. 10.1038/sj.eye.6700231.CrossRef
11.
Zurück zum Zitat Zenda S, Kawashima M, Nishio T, Kohno R, Nihei K, Onozawa M, Arahira S, Ogino T: Proton beam therapy as a nonsurgical approach to mucosal melanoma of the head and neck: a pilot study. Int J Radiat Oncol Biol Phys. 2011, 81: 135-139. 10.1016/j.ijrobp.2010.04.071.CrossRefPubMed Zenda S, Kawashima M, Nishio T, Kohno R, Nihei K, Onozawa M, Arahira S, Ogino T: Proton beam therapy as a nonsurgical approach to mucosal melanoma of the head and neck: a pilot study. Int J Radiat Oncol Biol Phys. 2011, 81: 135-139. 10.1016/j.ijrobp.2010.04.071.CrossRefPubMed
12.
Zurück zum Zitat Zenda S, Kohno R, Kawashima M, Arahira S, Nishio T, Tahara M, Hayashi R, Kishimoto S, Ogino T: Proton beam therapy for unresectable malignancies of the nasal cavity and paranasal sinuses. Int J Radiat Oncol Biol Phys. 2011, 81: 1473-1478. 10.1016/j.ijrobp.2010.08.009.CrossRefPubMed Zenda S, Kohno R, Kawashima M, Arahira S, Nishio T, Tahara M, Hayashi R, Kishimoto S, Ogino T: Proton beam therapy for unresectable malignancies of the nasal cavity and paranasal sinuses. Int J Radiat Oncol Biol Phys. 2011, 81: 1473-1478. 10.1016/j.ijrobp.2010.08.009.CrossRefPubMed
13.
Zurück zum Zitat Ginsberg J: Present Status of Meibomian gland carcinoma. Arch Ophthalmol. 1965, 73: 271-277. 10.1001/archopht.1965.00970030273022.CrossRefPubMed Ginsberg J: Present Status of Meibomian gland carcinoma. Arch Ophthalmol. 1965, 73: 271-277. 10.1001/archopht.1965.00970030273022.CrossRefPubMed
14.
Zurück zum Zitat Rao NA, Hidayat AA, McLean IW, Zimmerman LE: Sebaceous carcinomas of the ocular adnexa: a clinicopathologic study of 104 cases, with five-year follow-up data. Hum Pathol. 1982, 13: 113-122. 10.1016/S0046-8177(82)80115-9.CrossRefPubMed Rao NA, Hidayat AA, McLean IW, Zimmerman LE: Sebaceous carcinomas of the ocular adnexa: a clinicopathologic study of 104 cases, with five-year follow-up data. Hum Pathol. 1982, 13: 113-122. 10.1016/S0046-8177(82)80115-9.CrossRefPubMed
15.
Zurück zum Zitat Gardetto A, Rainer C, Ensinger C, Baldissera I, Piza-Katzer H: Sebaceous carcinoma of the eyelid: a rarity worth considering. Br J Ophthalmol. 2002, 86: 243-244. 10.1136/bjo.86.2.243.PubMedCentralCrossRefPubMed Gardetto A, Rainer C, Ensinger C, Baldissera I, Piza-Katzer H: Sebaceous carcinoma of the eyelid: a rarity worth considering. Br J Ophthalmol. 2002, 86: 243-244. 10.1136/bjo.86.2.243.PubMedCentralCrossRefPubMed
16.
Zurück zum Zitat Kass LG, Hornblass A: Sebaceous carcinoma of the ocular adnexa. Surv Ophthalmol. 1989, 33: 477-490. 10.1016/0039-6257(89)90049-0.CrossRefPubMed Kass LG, Hornblass A: Sebaceous carcinoma of the ocular adnexa. Surv Ophthalmol. 1989, 33: 477-490. 10.1016/0039-6257(89)90049-0.CrossRefPubMed
17.
Zurück zum Zitat Lan MC, Lan MY, Lin CZ, Ho DM, Ho CY: Sebaceous carcinoma of the eyelid with neck metastasis. Otolaryngol Head Neck Surg. 2007, 136: 670-671. 10.1016/j.otohns.2006.08.019.CrossRefPubMed Lan MC, Lan MY, Lin CZ, Ho DM, Ho CY: Sebaceous carcinoma of the eyelid with neck metastasis. Otolaryngol Head Neck Surg. 2007, 136: 670-671. 10.1016/j.otohns.2006.08.019.CrossRefPubMed
18.
Zurück zum Zitat Boniuk M, Zimmerman LE: Sebaceous carcinoma of the eyelid, eyebrow, caruncle, and orbit. Trans Am Acad Ophthalmol Otolaryngol. 1968, 72: 619-642.PubMed Boniuk M, Zimmerman LE: Sebaceous carcinoma of the eyelid, eyebrow, caruncle, and orbit. Trans Am Acad Ophthalmol Otolaryngol. 1968, 72: 619-642.PubMed
19.
Zurück zum Zitat Midena E, Angeli CD, Valenti M, de Belvis V, Boccato P: Treatment of conjunctival squamous cell carcinoma with topical 5-fluorouracil. Br J Ophthalmol. 2000, 84: 268-272. 10.1136/bjo.84.3.268.PubMedCentralCrossRefPubMed Midena E, Angeli CD, Valenti M, de Belvis V, Boccato P: Treatment of conjunctival squamous cell carcinoma with topical 5-fluorouracil. Br J Ophthalmol. 2000, 84: 268-272. 10.1136/bjo.84.3.268.PubMedCentralCrossRefPubMed
20.
Zurück zum Zitat Yeatts RP, Engelbrecht NE, Curry CD, Ford JG, Walter KA: 5-Fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea. Ophthalmology. 2000, 107: 2190-2195. 10.1016/S0161-6420(00)00389-4.CrossRefPubMed Yeatts RP, Engelbrecht NE, Curry CD, Ford JG, Walter KA: 5-Fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea. Ophthalmology. 2000, 107: 2190-2195. 10.1016/S0161-6420(00)00389-4.CrossRefPubMed
21.
Zurück zum Zitat Husain A, Blumenschein G, Esmaeli B: Treatment and outcomes for metastatic sebaceous cell carcinoma of the eyelid. Int J Dermatol. 2008, 47: 276-279. 10.1111/j.1365-4632.2008.03496.x.CrossRefPubMed Husain A, Blumenschein G, Esmaeli B: Treatment and outcomes for metastatic sebaceous cell carcinoma of the eyelid. Int J Dermatol. 2008, 47: 276-279. 10.1111/j.1365-4632.2008.03496.x.CrossRefPubMed
22.
Zurück zum Zitat Hata M, Koike I, Omura M, Maegawa J, Ogino I, Inoue T: Noninvasive and curative radiation therapy for sebaceous carcinoma of the eyelid. Int J Radiat Oncol Biol Phys. 2012, 82: 605-611. 10.1016/j.ijrobp.2010.12.006.CrossRefPubMed Hata M, Koike I, Omura M, Maegawa J, Ogino I, Inoue T: Noninvasive and curative radiation therapy for sebaceous carcinoma of the eyelid. Int J Radiat Oncol Biol Phys. 2012, 82: 605-611. 10.1016/j.ijrobp.2010.12.006.CrossRefPubMed
23.
Zurück zum Zitat Howrey RP, Lipham WJ, Schultz WH, Buckley EG, Dutton JJ, Klintworth GK, Rosoff PM: Sebaceous gland carcinoma: a subtle second malignancy following radiation therapy in patients with bilateral retinoblastoma. Cancer. 1998, 83: 767-771. 10.1002/(SICI)1097-0142(19980815)83:4<767::AID-CNCR20>3.0.CO;2-P.CrossRefPubMed Howrey RP, Lipham WJ, Schultz WH, Buckley EG, Dutton JJ, Klintworth GK, Rosoff PM: Sebaceous gland carcinoma: a subtle second malignancy following radiation therapy in patients with bilateral retinoblastoma. Cancer. 1998, 83: 767-771. 10.1002/(SICI)1097-0142(19980815)83:4<767::AID-CNCR20>3.0.CO;2-P.CrossRefPubMed
Metadaten
Titel
Surgical treatment of a solitary pulmonary metastasis from eyelid sebaceous carcinoma: report of a case
verfasst von
Kaoru Kaseda
Takashi Ohtsuka
Yuichiro Hayashi
Katsura Emoto
Keisuke Asakura
Ikuo Kamiyama
Taichiro Goto
Mitsutomo Kohno
Publikationsdatum
01.12.2014
Verlag
BioMed Central
Erschienen in
World Journal of Surgical Oncology / Ausgabe 1/2014
Elektronische ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-12-108

Weitere Artikel der Ausgabe 1/2014

World Journal of Surgical Oncology 1/2014 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.